march 18, 2014 - centers for disease control and prevention · 3/18/2014 · thomas m. shinnick,...
TRANSCRIPT
![Page 2: March 18, 2014 - Centers for Disease Control and Prevention · 3/18/2014 · Thomas M. Shinnick, PhD. Associate Director for Global Laboratory Activities . Division of Tuberculosis](https://reader033.vdocuments.site/reader033/viewer/2022050204/5f57a9e3ec48451c7d4a1a72/html5/thumbnails/2.jpg)
![Page 3: March 18, 2014 - Centers for Disease Control and Prevention · 3/18/2014 · Thomas M. Shinnick, PhD. Associate Director for Global Laboratory Activities . Division of Tuberculosis](https://reader033.vdocuments.site/reader033/viewer/2022050204/5f57a9e3ec48451c7d4a1a72/html5/thumbnails/3.jpg)
![Page 4: March 18, 2014 - Centers for Disease Control and Prevention · 3/18/2014 · Thomas M. Shinnick, PhD. Associate Director for Global Laboratory Activities . Division of Tuberculosis](https://reader033.vdocuments.site/reader033/viewer/2022050204/5f57a9e3ec48451c7d4a1a72/html5/thumbnails/4.jpg)
![Page 5: March 18, 2014 - Centers for Disease Control and Prevention · 3/18/2014 · Thomas M. Shinnick, PhD. Associate Director for Global Laboratory Activities . Division of Tuberculosis](https://reader033.vdocuments.site/reader033/viewer/2022050204/5f57a9e3ec48451c7d4a1a72/html5/thumbnails/5.jpg)
![Page 6: March 18, 2014 - Centers for Disease Control and Prevention · 3/18/2014 · Thomas M. Shinnick, PhD. Associate Director for Global Laboratory Activities . Division of Tuberculosis](https://reader033.vdocuments.site/reader033/viewer/2022050204/5f57a9e3ec48451c7d4a1a72/html5/thumbnails/6.jpg)
![Page 7: March 18, 2014 - Centers for Disease Control and Prevention · 3/18/2014 · Thomas M. Shinnick, PhD. Associate Director for Global Laboratory Activities . Division of Tuberculosis](https://reader033.vdocuments.site/reader033/viewer/2022050204/5f57a9e3ec48451c7d4a1a72/html5/thumbnails/7.jpg)
![Page 8: March 18, 2014 - Centers for Disease Control and Prevention · 3/18/2014 · Thomas M. Shinnick, PhD. Associate Director for Global Laboratory Activities . Division of Tuberculosis](https://reader033.vdocuments.site/reader033/viewer/2022050204/5f57a9e3ec48451c7d4a1a72/html5/thumbnails/8.jpg)
![Page 9: March 18, 2014 - Centers for Disease Control and Prevention · 3/18/2014 · Thomas M. Shinnick, PhD. Associate Director for Global Laboratory Activities . Division of Tuberculosis](https://reader033.vdocuments.site/reader033/viewer/2022050204/5f57a9e3ec48451c7d4a1a72/html5/thumbnails/9.jpg)
![Page 10: March 18, 2014 - Centers for Disease Control and Prevention · 3/18/2014 · Thomas M. Shinnick, PhD. Associate Director for Global Laboratory Activities . Division of Tuberculosis](https://reader033.vdocuments.site/reader033/viewer/2022050204/5f57a9e3ec48451c7d4a1a72/html5/thumbnails/10.jpg)
![Page 11: March 18, 2014 - Centers for Disease Control and Prevention · 3/18/2014 · Thomas M. Shinnick, PhD. Associate Director for Global Laboratory Activities . Division of Tuberculosis](https://reader033.vdocuments.site/reader033/viewer/2022050204/5f57a9e3ec48451c7d4a1a72/html5/thumbnails/11.jpg)
![Page 12: March 18, 2014 - Centers for Disease Control and Prevention · 3/18/2014 · Thomas M. Shinnick, PhD. Associate Director for Global Laboratory Activities . Division of Tuberculosis](https://reader033.vdocuments.site/reader033/viewer/2022050204/5f57a9e3ec48451c7d4a1a72/html5/thumbnails/12.jpg)
![Page 13: March 18, 2014 - Centers for Disease Control and Prevention · 3/18/2014 · Thomas M. Shinnick, PhD. Associate Director for Global Laboratory Activities . Division of Tuberculosis](https://reader033.vdocuments.site/reader033/viewer/2022050204/5f57a9e3ec48451c7d4a1a72/html5/thumbnails/13.jpg)
![Page 14: March 18, 2014 - Centers for Disease Control and Prevention · 3/18/2014 · Thomas M. Shinnick, PhD. Associate Director for Global Laboratory Activities . Division of Tuberculosis](https://reader033.vdocuments.site/reader033/viewer/2022050204/5f57a9e3ec48451c7d4a1a72/html5/thumbnails/14.jpg)
![Page 15: March 18, 2014 - Centers for Disease Control and Prevention · 3/18/2014 · Thomas M. Shinnick, PhD. Associate Director for Global Laboratory Activities . Division of Tuberculosis](https://reader033.vdocuments.site/reader033/viewer/2022050204/5f57a9e3ec48451c7d4a1a72/html5/thumbnails/15.jpg)
![Page 16: March 18, 2014 - Centers for Disease Control and Prevention · 3/18/2014 · Thomas M. Shinnick, PhD. Associate Director for Global Laboratory Activities . Division of Tuberculosis](https://reader033.vdocuments.site/reader033/viewer/2022050204/5f57a9e3ec48451c7d4a1a72/html5/thumbnails/16.jpg)
![Page 17: March 18, 2014 - Centers for Disease Control and Prevention · 3/18/2014 · Thomas M. Shinnick, PhD. Associate Director for Global Laboratory Activities . Division of Tuberculosis](https://reader033.vdocuments.site/reader033/viewer/2022050204/5f57a9e3ec48451c7d4a1a72/html5/thumbnails/17.jpg)
Persons with drug-resistant TB spread disease to others by respiratory droplets.
Antibiotics kill drug-sensitive organisms,
but not drug-resistant TB organisms.
![Page 18: March 18, 2014 - Centers for Disease Control and Prevention · 3/18/2014 · Thomas M. Shinnick, PhD. Associate Director for Global Laboratory Activities . Division of Tuberculosis](https://reader033.vdocuments.site/reader033/viewer/2022050204/5f57a9e3ec48451c7d4a1a72/html5/thumbnails/18.jpg)
Any
resistance
~1 million
Global Burden of Drug-resistant TB
8.6 million
TB Cases
Extensively
drug-resistant
(XDR) TB
43,200
Multidrug-resistant
(MDR) TB
450,000
![Page 19: March 18, 2014 - Centers for Disease Control and Prevention · 3/18/2014 · Thomas M. Shinnick, PhD. Associate Director for Global Laboratory Activities . Division of Tuberculosis](https://reader033.vdocuments.site/reader033/viewer/2022050204/5f57a9e3ec48451c7d4a1a72/html5/thumbnails/19.jpg)
![Page 20: March 18, 2014 - Centers for Disease Control and Prevention · 3/18/2014 · Thomas M. Shinnick, PhD. Associate Director for Global Laboratory Activities . Division of Tuberculosis](https://reader033.vdocuments.site/reader033/viewer/2022050204/5f57a9e3ec48451c7d4a1a72/html5/thumbnails/20.jpg)
![Page 21: March 18, 2014 - Centers for Disease Control and Prevention · 3/18/2014 · Thomas M. Shinnick, PhD. Associate Director for Global Laboratory Activities . Division of Tuberculosis](https://reader033.vdocuments.site/reader033/viewer/2022050204/5f57a9e3ec48451c7d4a1a72/html5/thumbnails/21.jpg)
![Page 22: March 18, 2014 - Centers for Disease Control and Prevention · 3/18/2014 · Thomas M. Shinnick, PhD. Associate Director for Global Laboratory Activities . Division of Tuberculosis](https://reader033.vdocuments.site/reader033/viewer/2022050204/5f57a9e3ec48451c7d4a1a72/html5/thumbnails/22.jpg)
![Page 23: March 18, 2014 - Centers for Disease Control and Prevention · 3/18/2014 · Thomas M. Shinnick, PhD. Associate Director for Global Laboratory Activities . Division of Tuberculosis](https://reader033.vdocuments.site/reader033/viewer/2022050204/5f57a9e3ec48451c7d4a1a72/html5/thumbnails/23.jpg)
![Page 24: March 18, 2014 - Centers for Disease Control and Prevention · 3/18/2014 · Thomas M. Shinnick, PhD. Associate Director for Global Laboratory Activities . Division of Tuberculosis](https://reader033.vdocuments.site/reader033/viewer/2022050204/5f57a9e3ec48451c7d4a1a72/html5/thumbnails/24.jpg)
![Page 25: March 18, 2014 - Centers for Disease Control and Prevention · 3/18/2014 · Thomas M. Shinnick, PhD. Associate Director for Global Laboratory Activities . Division of Tuberculosis](https://reader033.vdocuments.site/reader033/viewer/2022050204/5f57a9e3ec48451c7d4a1a72/html5/thumbnails/25.jpg)
![Page 26: March 18, 2014 - Centers for Disease Control and Prevention · 3/18/2014 · Thomas M. Shinnick, PhD. Associate Director for Global Laboratory Activities . Division of Tuberculosis](https://reader033.vdocuments.site/reader033/viewer/2022050204/5f57a9e3ec48451c7d4a1a72/html5/thumbnails/26.jpg)
![Page 27: March 18, 2014 - Centers for Disease Control and Prevention · 3/18/2014 · Thomas M. Shinnick, PhD. Associate Director for Global Laboratory Activities . Division of Tuberculosis](https://reader033.vdocuments.site/reader033/viewer/2022050204/5f57a9e3ec48451c7d4a1a72/html5/thumbnails/27.jpg)
Thomas M. Shinnick, PhD Associate Director for Global Laboratory Activities
Division of Tuberculosis Elimination National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention
![Page 28: March 18, 2014 - Centers for Disease Control and Prevention · 3/18/2014 · Thomas M. Shinnick, PhD. Associate Director for Global Laboratory Activities . Division of Tuberculosis](https://reader033.vdocuments.site/reader033/viewer/2022050204/5f57a9e3ec48451c7d4a1a72/html5/thumbnails/28.jpg)
![Page 29: March 18, 2014 - Centers for Disease Control and Prevention · 3/18/2014 · Thomas M. Shinnick, PhD. Associate Director for Global Laboratory Activities . Division of Tuberculosis](https://reader033.vdocuments.site/reader033/viewer/2022050204/5f57a9e3ec48451c7d4a1a72/html5/thumbnails/29.jpg)
![Page 30: March 18, 2014 - Centers for Disease Control and Prevention · 3/18/2014 · Thomas M. Shinnick, PhD. Associate Director for Global Laboratory Activities . Division of Tuberculosis](https://reader033.vdocuments.site/reader033/viewer/2022050204/5f57a9e3ec48451c7d4a1a72/html5/thumbnails/30.jpg)
Uses simple sputum processing steps
Cartridge Sample 4 Module Instrument Module
![Page 31: March 18, 2014 - Centers for Disease Control and Prevention · 3/18/2014 · Thomas M. Shinnick, PhD. Associate Director for Global Laboratory Activities . Division of Tuberculosis](https://reader033.vdocuments.site/reader033/viewer/2022050204/5f57a9e3ec48451c7d4a1a72/html5/thumbnails/31.jpg)
WHO recommended treatment of RIF-R TB is similar to MDR TB
![Page 32: March 18, 2014 - Centers for Disease Control and Prevention · 3/18/2014 · Thomas M. Shinnick, PhD. Associate Director for Global Laboratory Activities . Division of Tuberculosis](https://reader033.vdocuments.site/reader033/viewer/2022050204/5f57a9e3ec48451c7d4a1a72/html5/thumbnails/32.jpg)
![Page 33: March 18, 2014 - Centers for Disease Control and Prevention · 3/18/2014 · Thomas M. Shinnick, PhD. Associate Director for Global Laboratory Activities . Division of Tuberculosis](https://reader033.vdocuments.site/reader033/viewer/2022050204/5f57a9e3ec48451c7d4a1a72/html5/thumbnails/33.jpg)
![Page 34: March 18, 2014 - Centers for Disease Control and Prevention · 3/18/2014 · Thomas M. Shinnick, PhD. Associate Director for Global Laboratory Activities . Division of Tuberculosis](https://reader033.vdocuments.site/reader033/viewer/2022050204/5f57a9e3ec48451c7d4a1a72/html5/thumbnails/34.jpg)
Xpert® MTB/RIF may reduce the
median time to treatment For culture-diagnosed cases,
from 56 days to 5 days
For MDR TB,
from 86 days to 5 days
![Page 35: March 18, 2014 - Centers for Disease Control and Prevention · 3/18/2014 · Thomas M. Shinnick, PhD. Associate Director for Global Laboratory Activities . Division of Tuberculosis](https://reader033.vdocuments.site/reader033/viewer/2022050204/5f57a9e3ec48451c7d4a1a72/html5/thumbnails/35.jpg)
![Page 36: March 18, 2014 - Centers for Disease Control and Prevention · 3/18/2014 · Thomas M. Shinnick, PhD. Associate Director for Global Laboratory Activities . Division of Tuberculosis](https://reader033.vdocuments.site/reader033/viewer/2022050204/5f57a9e3ec48451c7d4a1a72/html5/thumbnails/36.jpg)
![Page 37: March 18, 2014 - Centers for Disease Control and Prevention · 3/18/2014 · Thomas M. Shinnick, PhD. Associate Director for Global Laboratory Activities . Division of Tuberculosis](https://reader033.vdocuments.site/reader033/viewer/2022050204/5f57a9e3ec48451c7d4a1a72/html5/thumbnails/37.jpg)
![Page 38: March 18, 2014 - Centers for Disease Control and Prevention · 3/18/2014 · Thomas M. Shinnick, PhD. Associate Director for Global Laboratory Activities . Division of Tuberculosis](https://reader033.vdocuments.site/reader033/viewer/2022050204/5f57a9e3ec48451c7d4a1a72/html5/thumbnails/38.jpg)
No TB drugs
currently in
phase I trials
![Page 39: March 18, 2014 - Centers for Disease Control and Prevention · 3/18/2014 · Thomas M. Shinnick, PhD. Associate Director for Global Laboratory Activities . Division of Tuberculosis](https://reader033.vdocuments.site/reader033/viewer/2022050204/5f57a9e3ec48451c7d4a1a72/html5/thumbnails/39.jpg)
Bedaquiline
![Page 40: March 18, 2014 - Centers for Disease Control and Prevention · 3/18/2014 · Thomas M. Shinnick, PhD. Associate Director for Global Laboratory Activities . Division of Tuberculosis](https://reader033.vdocuments.site/reader033/viewer/2022050204/5f57a9e3ec48451c7d4a1a72/html5/thumbnails/40.jpg)
![Page 41: March 18, 2014 - Centers for Disease Control and Prevention · 3/18/2014 · Thomas M. Shinnick, PhD. Associate Director for Global Laboratory Activities . Division of Tuberculosis](https://reader033.vdocuments.site/reader033/viewer/2022050204/5f57a9e3ec48451c7d4a1a72/html5/thumbnails/41.jpg)
Delamanid
![Page 42: March 18, 2014 - Centers for Disease Control and Prevention · 3/18/2014 · Thomas M. Shinnick, PhD. Associate Director for Global Laboratory Activities . Division of Tuberculosis](https://reader033.vdocuments.site/reader033/viewer/2022050204/5f57a9e3ec48451c7d4a1a72/html5/thumbnails/42.jpg)
www.ema.europa.eu
www.clinicaltrials.gov/ct2/show/NCT01424670?term=delamanid&rank=3
![Page 43: March 18, 2014 - Centers for Disease Control and Prevention · 3/18/2014 · Thomas M. Shinnick, PhD. Associate Director for Global Laboratory Activities . Division of Tuberculosis](https://reader033.vdocuments.site/reader033/viewer/2022050204/5f57a9e3ec48451c7d4a1a72/html5/thumbnails/43.jpg)
![Page 44: March 18, 2014 - Centers for Disease Control and Prevention · 3/18/2014 · Thomas M. Shinnick, PhD. Associate Director for Global Laboratory Activities . Division of Tuberculosis](https://reader033.vdocuments.site/reader033/viewer/2022050204/5f57a9e3ec48451c7d4a1a72/html5/thumbnails/44.jpg)
![Page 45: March 18, 2014 - Centers for Disease Control and Prevention · 3/18/2014 · Thomas M. Shinnick, PhD. Associate Director for Global Laboratory Activities . Division of Tuberculosis](https://reader033.vdocuments.site/reader033/viewer/2022050204/5f57a9e3ec48451c7d4a1a72/html5/thumbnails/45.jpg)
![Page 46: March 18, 2014 - Centers for Disease Control and Prevention · 3/18/2014 · Thomas M. Shinnick, PhD. Associate Director for Global Laboratory Activities . Division of Tuberculosis](https://reader033.vdocuments.site/reader033/viewer/2022050204/5f57a9e3ec48451c7d4a1a72/html5/thumbnails/46.jpg)
Proportion of patients with a successful outcome in the
treatment of multidrug-resistant tuberculosis
(Clo = clofazimine; Gati = gatifloxacin; INH = isoniazid;
Oflo = ofloxacin; Pth = prothionamide)
![Page 47: March 18, 2014 - Centers for Disease Control and Prevention · 3/18/2014 · Thomas M. Shinnick, PhD. Associate Director for Global Laboratory Activities . Division of Tuberculosis](https://reader033.vdocuments.site/reader033/viewer/2022050204/5f57a9e3ec48451c7d4a1a72/html5/thumbnails/47.jpg)
![Page 48: March 18, 2014 - Centers for Disease Control and Prevention · 3/18/2014 · Thomas M. Shinnick, PhD. Associate Director for Global Laboratory Activities . Division of Tuberculosis](https://reader033.vdocuments.site/reader033/viewer/2022050204/5f57a9e3ec48451c7d4a1a72/html5/thumbnails/48.jpg)
Xpert®
![Page 49: March 18, 2014 - Centers for Disease Control and Prevention · 3/18/2014 · Thomas M. Shinnick, PhD. Associate Director for Global Laboratory Activities . Division of Tuberculosis](https://reader033.vdocuments.site/reader033/viewer/2022050204/5f57a9e3ec48451c7d4a1a72/html5/thumbnails/49.jpg)
![Page 50: March 18, 2014 - Centers for Disease Control and Prevention · 3/18/2014 · Thomas M. Shinnick, PhD. Associate Director for Global Laboratory Activities . Division of Tuberculosis](https://reader033.vdocuments.site/reader033/viewer/2022050204/5f57a9e3ec48451c7d4a1a72/html5/thumbnails/50.jpg)
![Page 51: March 18, 2014 - Centers for Disease Control and Prevention · 3/18/2014 · Thomas M. Shinnick, PhD. Associate Director for Global Laboratory Activities . Division of Tuberculosis](https://reader033.vdocuments.site/reader033/viewer/2022050204/5f57a9e3ec48451c7d4a1a72/html5/thumbnails/51.jpg)
![Page 52: March 18, 2014 - Centers for Disease Control and Prevention · 3/18/2014 · Thomas M. Shinnick, PhD. Associate Director for Global Laboratory Activities . Division of Tuberculosis](https://reader033.vdocuments.site/reader033/viewer/2022050204/5f57a9e3ec48451c7d4a1a72/html5/thumbnails/52.jpg)
![Page 53: March 18, 2014 - Centers for Disease Control and Prevention · 3/18/2014 · Thomas M. Shinnick, PhD. Associate Director for Global Laboratory Activities . Division of Tuberculosis](https://reader033.vdocuments.site/reader033/viewer/2022050204/5f57a9e3ec48451c7d4a1a72/html5/thumbnails/53.jpg)
![Page 54: March 18, 2014 - Centers for Disease Control and Prevention · 3/18/2014 · Thomas M. Shinnick, PhD. Associate Director for Global Laboratory Activities . Division of Tuberculosis](https://reader033.vdocuments.site/reader033/viewer/2022050204/5f57a9e3ec48451c7d4a1a72/html5/thumbnails/54.jpg)
Global
incidence
decreased 15%
Global
mortality
decreased 40%
![Page 55: March 18, 2014 - Centers for Disease Control and Prevention · 3/18/2014 · Thomas M. Shinnick, PhD. Associate Director for Global Laboratory Activities . Division of Tuberculosis](https://reader033.vdocuments.site/reader033/viewer/2022050204/5f57a9e3ec48451c7d4a1a72/html5/thumbnails/55.jpg)
www.un.org/millenniumgoals/
![Page 56: March 18, 2014 - Centers for Disease Control and Prevention · 3/18/2014 · Thomas M. Shinnick, PhD. Associate Director for Global Laboratory Activities . Division of Tuberculosis](https://reader033.vdocuments.site/reader033/viewer/2022050204/5f57a9e3ec48451c7d4a1a72/html5/thumbnails/56.jpg)
![Page 57: March 18, 2014 - Centers for Disease Control and Prevention · 3/18/2014 · Thomas M. Shinnick, PhD. Associate Director for Global Laboratory Activities . Division of Tuberculosis](https://reader033.vdocuments.site/reader033/viewer/2022050204/5f57a9e3ec48451c7d4a1a72/html5/thumbnails/57.jpg)
WHO. Global Tuberculosis Report 2013
Global Plan to Stop TB. Available at: www.stoptb.org/global/plan/
![Page 58: March 18, 2014 - Centers for Disease Control and Prevention · 3/18/2014 · Thomas M. Shinnick, PhD. Associate Director for Global Laboratory Activities . Division of Tuberculosis](https://reader033.vdocuments.site/reader033/viewer/2022050204/5f57a9e3ec48451c7d4a1a72/html5/thumbnails/58.jpg)
![Page 59: March 18, 2014 - Centers for Disease Control and Prevention · 3/18/2014 · Thomas M. Shinnick, PhD. Associate Director for Global Laboratory Activities . Division of Tuberculosis](https://reader033.vdocuments.site/reader033/viewer/2022050204/5f57a9e3ec48451c7d4a1a72/html5/thumbnails/59.jpg)
Health systems
strengthening essential
to realize full potential of
GeneXpert® scale-up
![Page 60: March 18, 2014 - Centers for Disease Control and Prevention · 3/18/2014 · Thomas M. Shinnick, PhD. Associate Director for Global Laboratory Activities . Division of Tuberculosis](https://reader033.vdocuments.site/reader033/viewer/2022050204/5f57a9e3ec48451c7d4a1a72/html5/thumbnails/60.jpg)
![Page 61: March 18, 2014 - Centers for Disease Control and Prevention · 3/18/2014 · Thomas M. Shinnick, PhD. Associate Director for Global Laboratory Activities . Division of Tuberculosis](https://reader033.vdocuments.site/reader033/viewer/2022050204/5f57a9e3ec48451c7d4a1a72/html5/thumbnails/61.jpg)
![Page 62: March 18, 2014 - Centers for Disease Control and Prevention · 3/18/2014 · Thomas M. Shinnick, PhD. Associate Director for Global Laboratory Activities . Division of Tuberculosis](https://reader033.vdocuments.site/reader033/viewer/2022050204/5f57a9e3ec48451c7d4a1a72/html5/thumbnails/62.jpg)
*The GLC serves as a technical advisory body to the Stop TB Partnership
and the World Health Organization
![Page 63: March 18, 2014 - Centers for Disease Control and Prevention · 3/18/2014 · Thomas M. Shinnick, PhD. Associate Director for Global Laboratory Activities . Division of Tuberculosis](https://reader033.vdocuments.site/reader033/viewer/2022050204/5f57a9e3ec48451c7d4a1a72/html5/thumbnails/63.jpg)
![Page 64: March 18, 2014 - Centers for Disease Control and Prevention · 3/18/2014 · Thomas M. Shinnick, PhD. Associate Director for Global Laboratory Activities . Division of Tuberculosis](https://reader033.vdocuments.site/reader033/viewer/2022050204/5f57a9e3ec48451c7d4a1a72/html5/thumbnails/64.jpg)
90
%
Red line = single chain
of transmission
![Page 65: March 18, 2014 - Centers for Disease Control and Prevention · 3/18/2014 · Thomas M. Shinnick, PhD. Associate Director for Global Laboratory Activities . Division of Tuberculosis](https://reader033.vdocuments.site/reader033/viewer/2022050204/5f57a9e3ec48451c7d4a1a72/html5/thumbnails/65.jpg)
![Page 66: March 18, 2014 - Centers for Disease Control and Prevention · 3/18/2014 · Thomas M. Shinnick, PhD. Associate Director for Global Laboratory Activities . Division of Tuberculosis](https://reader033.vdocuments.site/reader033/viewer/2022050204/5f57a9e3ec48451c7d4a1a72/html5/thumbnails/66.jpg)
1996-99
1999-02
2003-07
![Page 67: March 18, 2014 - Centers for Disease Control and Prevention · 3/18/2014 · Thomas M. Shinnick, PhD. Associate Director for Global Laboratory Activities . Division of Tuberculosis](https://reader033.vdocuments.site/reader033/viewer/2022050204/5f57a9e3ec48451c7d4a1a72/html5/thumbnails/67.jpg)
![Page 68: March 18, 2014 - Centers for Disease Control and Prevention · 3/18/2014 · Thomas M. Shinnick, PhD. Associate Director for Global Laboratory Activities . Division of Tuberculosis](https://reader033.vdocuments.site/reader033/viewer/2022050204/5f57a9e3ec48451c7d4a1a72/html5/thumbnails/68.jpg)
March 18, 2014